论文部分内容阅读
目的观察艾迪注射液改善进展期胃癌化疗患者生活质量问卷评分。方法连续选择近期接受化疗的进展期胃癌患者77例,根据自愿原则(经济条件允许)分组,接受艾迪注射液治疗(治疗组)35例和未接受艾迪注射液治疗(对照组)42例,治疗结束后进行生活质量问卷(OLQ-STO22)评分。结果治疗组生活质量问卷中的吞咽困难、胃部疼痛、呃逆、口干、味觉、饮食受限、身体外观和焦虑等多数分量表得分及OLQ-STO22总分均明显高于对照组(p均<0.01～0.05)。结论艾迪注射液可明显改善进展期胃癌化疗患者生活质量问卷评分。
Objective To investigate the effect of Aidi Injection on improving the quality of life of patients with advanced gastric cancer treated with chemotherapy. Methods A total of 77 patients with advanced gastric cancer undergoing chemotherapy were enrolled in this study. According to the voluntary principle (economic conditions), 35 patients received Aidi Injection (treatment group) and 42 patients who did not receive Aidi Injection (control group) , After the end of treatment quality of life questionnaire (OLQ-STO22) score. Results The QOL scores and scores of OLQ-STO22 in the treatment group were significantly higher than those in the control group (dysphagia, stomach pain, hiccups, dry mouth, taste, diet restriction, body appearance and anxiety scores, etc.) <0.01 ~ 0.05). Conclusion Aidi injection can significantly improve the quality of life of patients with advanced gastric cancer chemotherapy score.